Blog
Jiva.ai Raises £1.3M for Prostate Diagnostics and AI Platform Expansion
£1.3M seed financing raised from VC, state-aid backed entity and angel investors. The capital will be used to grow the team and productionise the existing prostate cancer work as well as build a general purpose multimodal AI platform. The platform will be additionally...
Hertility Health pulls in £4.2M for accessible diagnostics in women’s health
Revolutionising the world of hormone and reproductive health, the new London-based women’s health startup Hertility Healthhas announced the closing of a £4.2 million seed funding. The funding round was led by LocalGlobe – one of the UK’s most prolific seed investors,...
Vesynta’s Step Change in Cancer Drug Dosing
Vesynta’s mission is to remodel chemotherapeutic dosing regimens, allowing for near-real-time adjustment of a patient's cancer treatment. At the core of this step-change is the ability to measure a patient’s unique “drug exposure” (the concentration of...
P4 Precision Medicine Accelerator and Nuffield Health Announce Strategic Partnership to Fast-Track Innovation in Precision Medicine
PRESS RELEASE London , 11 November 2020 P4 Precision Medicine Accelerator powered by Barclays Eagle Labs and the UK’s largest healthcare charity, Nuffield Health, today announced a strategic partnership to accelerate the development and adoption of precision medicine...
HN Appoints Managing Director Mark England as Chief Executive Officer and Expands its Leadership Team and Board
PRESS RELEASE LOCATION: London, UK HN APPOINTS MANAGING DIRECTOR MARK ENGLAND AS CHIEF EXECUTIVE OFFICER AND EXPANDS ITS LEADERSHIP TEAM AND BOARD Mark England has been named chief executive officer (CEO) of healthcare company HN, the company announced today. Dr...
Shaping the Future of Healthcare with Jiva.ai
Written by Marta Caldeira, 24th September 2020 Founded by Dr Manish Patel and Dr Chetan Kaher in 2019, British startup Jiva.ai is transforming the world of healthcare by providing a much-needed framework for the integration of different artificial intelligence (AI)...
My Personal Therapeutics: Turning Science Fiction into Science Reality
Written by Callum Oddy, 7th September 2020 As our knowledge of cancer and how to treat it evolves, scientists and medical professionals are searching for more ways to personalise and refine cancer treatments. My Personal Therapeutics is a company based in London that...
Pear Bio and the Ever-expanding World of Tailored Oncology
Written by Oscar Drury, 25th August 2020 In a world reliant upon standard patient care within oncology, Pear Bio looks to reform how pharmaceutical companies trial new drugs in addition to how doctors treat patients. This upheaval of the treatment status quo aims to...
Health Navigator Announces Major Rebranding to Reflect Growth and New Product Portfolio
PRESS RELEASE: For immediate release DATE: 13.08.2020 LOCATION: London, UK HEALTH-TECH COMPANY, HEALTH NAVIGATOR ANNOUNCES MAJOR REBRANDING TO REFLECT GROWTH AND NEW PRODUCT PORTFOLIO Health Navigator has announced a major rebranding to showcase the company’s...
NHSX Precision Medicine Case Study – Prof Phil Beales
Precision medicine encompasses predictive, preventive, personalised and participatory medicine (also termed P4 medicine). It is moving from the traditional one-size-fits-all form of medicine to more preventative, personalised, data-driven disease management model that...